Medical Research News

RSS

Scientists identify calpeptin as potential inhibitor of SARS-CoV-2

A team of US-based scientists has recently conducted a robust high-throughput screening to identify potential entry inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The screening identifies calpeptin as a potent and highly specific inhibitor of SARS-CoV-2 and its variants. The study is currently available on the bioRxiv* preprint server.

9 Aug 2021

Cetylpyridinium chloride-containing mouthwashes shown to inhibit SARS-CoV-2 in oral cavity

A team of international scientists has recently demonstrated the usefulness of cetylpyridinium chloride-containing mouthwashes in inhibiting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and reducing the risk of viral transmission. The study is currently available on the bioRxiv* preprint server.

9 Aug 2021

Computational study identifies key areas of the SARS-CoV-2 genome prone to mutation

By retrieving 329,942 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) records from the GISAID database, researchers from a software company in Cambridge described genetic variability of SARS-CoV-2 in order to inform further studies. Their findings are currently available on the bioRxiv* preprint server while it undergoes peer review.

9 Aug 2021

New insight into impact of SARS-CoV-2 mutations on receptor binding

A recent study by Canadian researchers, currently available on the bioRxiv* preprint server, contributes to the growing body of literature on emerging variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by appraising the impact of single mutations on their overall antigenicity and binding affinity for the angiotensin-converting enzyme 2 (ACE2) receptor.

9 Aug 2021

Virus-like particles reveal unexpected mechanism for increased fitness and spread of SARS-CoV-2

Researchers in the United States have developed a new model for testing mutations in the four structural proteins of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

9 Aug 2021

New phylogenomic platform identifies increased recombination rates in SARS-CoV-2

Researchers in the United States, Australia and the UK have developed a novel method that enables the evolutionary ancestry (phylogeny) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to be comprehensively searched for recombinant lineages.

8 Aug 2021

Surfactant-coated nanoparticle applications in nanomedicine and food

A group of researchers critically review the use of surfactant-coated nanoparticles in the fields of nanomedicine and food nanotechnology.

8 Aug 2021

High rates of COVID-19 vaccine motivation among Latinx parents – a single center study

A new study demonstrates high motivation among Latinx parents to get their children vaccinated against COVID-19.

8 Aug 2021

Long COVID may be due to persistent immune disturbances

A new study discusses abnormalities in the immune response following COVID-19 in samples collected from patients who have recovered from COVID-19.

8 Aug 2021

New study describes SARS-CoV-2 ExoN enzyme that promotes antiviral resistance

A new study describes the structure of a crucial enzyme present in SARS-CoV-2.

8 Aug 2021

Availability heuristic plays a role in how physicians make complex testing decisions

Emergency department physicians who saw patients with a pulmonary embolism - a blood clot in the lung - were about 15% likelier over the next 10 days to test subsequent patients for the same thing.

8 Aug 2021

Education and employment experiences in early adulthood play a role in later life cardiovascular health

New research published today in the Journal of Epidemiology and Community Health has found that education and employment experiences in early adulthood contribute to cardiovascular health inequalities in later life, independent of occupation and family income in mid-adulthood.

6 Aug 2021

New immunotherapy strategy can eliminate pancreatic tumors in mice

Pancreatic cancer, which affects about 60,000 Americans every year, is one of the deadliest forms of cancer. After diagnosis, fewer than 10 percent of patients survive for five years.

6 Aug 2021

Light therapy may speed up the healing of burns by activating growth protein

Light therapy may accelerate the healing of burns, according to a University at Buffalo-led study.

6 Aug 2021

Researchers demonstrate how to improve patient-centered care for sex workers

Sex workers face discrimination within healthcare settings that limit their access to safe care. Researchers at the University of Illinois Chicago's College of Nursing have recently published a paper demonstrating how patient-centered care for sex workers could be implemented.

6 Aug 2021

Study examines the effect of vitamin D supplementation on kidney health in adults with prediabetes

A recent clinical trial described in CJASN has examined the potential of vitamin D supplementation for protecting the kidney health of individuals with pre-diabetes.

6 Aug 2021

Review: Quality improvement studies in Ireland conform to high reporting standards

A review by RCSI University of Medicine and Health Sciences in collaboration with the HSE National Quality Improvement Team has found that quality improvement (QI) studies in Ireland over a five-year period conformed to high reporting standards and enhanced multiple elements of healthcare quality.

6 Aug 2021

Scientists use AI to identify new biomarkers for breast cancer

Scientists at Case Western Reserve University have used Artificial Intelligence (AI) to identify new biomarkers for breast cancer that can predict whether the cancer will return after treatment - and which can be identified from routinely acquired tissue biopsy samples of early-stage breast cancer.

6 Aug 2021

New study offers insight into how high-risk form of blood cancer can develop in children

In some children with acute myeloid leukemia, cancer cells have the same amount of DNA changes as healthy blood stem cells.

6 Aug 2021

Pfizer/BioNTech COVID-19 vaccine offers decreased protection six months after second dose, suggests Israeli study

A recent study published on the preprint server medRxiv* determines whether the time elapsed since the second dose of the BNT162b2 vaccine is associated with an increased risk of breakthrough SARS-CoV-2 infection.

6 Aug 2021

Medical Research News

Scientists identify calpeptin as potential inhibitor of SARS-CoV-2

Cetylpyridinium chloride-containing mouthwashes shown to inhibit SARS-CoV-2 in oral cavity

Computational study identifies key areas of the SARS-CoV-2 genome prone to mutation

New insight into impact of SARS-CoV-2 mutations on receptor binding

Virus-like particles reveal unexpected mechanism for increased fitness and spread of SARS-CoV-2

New phylogenomic platform identifies increased recombination rates in SARS-CoV-2

Surfactant-coated nanoparticle applications in nanomedicine and food

High rates of COVID-19 vaccine motivation among Latinx parents – a single center study

Long COVID may be due to persistent immune disturbances

New study describes SARS-CoV-2 ExoN enzyme that promotes antiviral resistance

Availability heuristic plays a role in how physicians make complex testing decisions

Education and employment experiences in early adulthood play a role in later life cardiovascular health

New immunotherapy strategy can eliminate pancreatic tumors in mice

Light therapy may speed up the healing of burns by activating growth protein

Researchers demonstrate how to improve patient-centered care for sex workers

Study examines the effect of vitamin D supplementation on kidney health in adults with prediabetes

Review: Quality improvement studies in Ireland conform to high reporting standards

Scientists use AI to identify new biomarkers for breast cancer

New study offers insight into how high-risk form of blood cancer can develop in children

Pfizer/BioNTech COVID-19 vaccine offers decreased protection six months after second dose, suggests Israeli study

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News